ascopubs.org

Rationale and study design of the KOV-HIPEC-04: A phase III randomized controlled trial in primary stage III and IV ovarian cancer after interval cytoreductive surgery (FOCUS).

A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer (KOV-HIPEC-02). This is an ASCO Meeting Abstract from ...
ascopubs.org

Effect of an Invitation or the Effect of Participation: What Should Randomized Controlled Trials of Cancer Screening Examine?

Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
Fierce Biotech

Small pools, big ideas: How the rare disease community is reimagining clinical trials

The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...

How a tiny circle of repeat offenders poisoned 100s of gold-standard medical trials for over a decade

Randomized Controlled Trials (RCTs) are the gold standard of medical research as random assignment approach helps eliminate ...

Alto Settles on Trials for Depression Drug

Alto Neuroscience, Inc. (NYSE: ANRO) shares fell first thing Tuesday. The company, a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today ...
Healthy DebateOpinion

Expanding dementia prevention and care beyond randomized control trials

In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...